Free Trial

CG Oncology (CGON) Institutional Ownership

$35.22
-1.50 (-4.08%)
(As of 07/19/2024 08:55 PM ET)

Institutional Ownership Changes (13F Filings) for CG Oncology (NASDAQ:CGON)

Current
Institutional Ownership
Percentage
26.56%
Number of
Institutional Buyers
(last 12 months)
15
Total
Institutional Inflows
(last 12 months)
$650.13M
Number of
Institutional Sellers
(last 12 months)
0
Get CGON Insider Trade Alerts

Want to know when executives and insiders are buying or selling CG Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CGON Institutional Buying and Selling by Quarter

CG Oncology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024RA Capital Management L.P.1,397,433$61.35M0.8%N/A2.097%
5/16/2024California State Teachers Retirement System2,341$103K0.0%N/A0.004%
5/16/2024Janus Henderson Group PLC1,521,432$66.76M0.0%N/A2.283%
5/16/2024BVF Inc. IL1,884,191$82.72M2.3%N/A2.827%
5/16/2024Blackstone Inc.25,000$1.10M0.0%N/A0.038%
5/15/2024Price T Rowe Associates Inc. MD992,118$43.56M0.0%N/A1.489%
5/15/2024Avoro Capital Advisors LLC700,000$30.73M0.4%N/A1.050%
5/14/2024StemPoint Capital LP40,723$1.79M0.5%N/A0.061%
5/14/2024Decheng Capital LLC5,458,810$239.64M32.1%N/A8.191%
5/14/2024American International Group Inc.306,226$13.44M0.0%N/A0.460%
5/13/2024Ameritas Investment Partners Inc.2,320$102K0.0%N/A0.003%
5/10/2024Vanguard Group Inc.2,225,018$97.68M0.0%N/A3.339%
5/7/2024TimesSquare Capital Management LLC224,073$9.84M0.1%N/A0.336%
5/1/2024Capstone Investment Advisors LLC18,354$806K0.0%N/A0.028%
5/1/2024BNP Paribas Financial Markets11,198$492K0.0%N/A0.017%
(Data available from 1/1/2016 forward)

CGON Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CGON shares?

During the previous two years, 15 institutional investors and hedge funds held shares of CG Oncology. The most heavily invested institutionals were Decheng Capital LLC ($239.64M), Vanguard Group Inc. ($97.68M), BVF Inc. IL ($82.72M), Janus Henderson Group PLC ($66.76M), RA Capital Management L.P. ($61.35M), Price T Rowe Associates Inc. MD ($43.56M), and Avoro Capital Advisors LLC ($30.73M).Learn more on CGON's institutional investors.

What percentage of CG Oncology stock is owned by institutional investors?

26.56% of CG Oncology stock is owned by institutional investors. Learn more on CGON's institutional investor holdings.

Which institutional investors have been buying CG Oncology stock?

Of the 15 institutional investors that purchased CG Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($5.46M), Vanguard Group Inc. ($2.23M), BVF Inc. IL ($1.88M), Janus Henderson Group PLC ($1.52M), RA Capital Management L.P. ($1.40M), Price T Rowe Associates Inc. MD ($992.12K), and Avoro Capital Advisors LLC ($700K).

How much institutional buying is happening at CG Oncology?

Institutional investors have bought a total of 14,809,237 shares in the last 24 months. This purchase volume represents approximately $650.13M in transactions.


This page (NASDAQ:CGON) was last updated on 7/22/2024 by MarketBeat.com Staff

From Our Partners